Jilin Province Huinan Changlong Bio-pharmacy Company Limited

HKSE 8049.HK

Jilin Province Huinan Changlong Bio-pharmacy Company Limited Net Cash Used For Investing Activities for the year ending December 31, 2023: USD 15.36 M

Jilin Province Huinan Changlong Bio-pharmacy Company Limited Net Cash Used For Investing Activities is USD 15.36 M for the year ending December 31, 2023, a 189.84% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Jilin Province Huinan Changlong Bio-pharmacy Company Limited Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -17.10 M, a 32.37% change year over year.
  • Jilin Province Huinan Changlong Bio-pharmacy Company Limited Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -25.28 M, a 32.61% change year over year.
  • Jilin Province Huinan Changlong Bio-pharmacy Company Limited Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -37.51 M, a -102.39% change year over year.
  • Jilin Province Huinan Changlong Bio-pharmacy Company Limited Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -18.53 M, a -51.66% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
SV Wall Street
HKSE: 8049.HK

Jilin Province Huinan Changlong Bio-pharmacy Company Limited

CEO Mr. Hong Zhang
IPO Date May 24, 2001
Location Hong Kong
Headquarters Grand Plaza, Office Tower Two
Employees 678
Sector Healthcare
Industries
Description

Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers tablets, capsules, pills, Chinese medicine pretreatment and extraction products, powders for injections, lyophilized powder for injections, small volume injection solutions, APIs, and granules. The company markets its products under the Changlong and Qing Tong brands. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.

StockViz Staff

February 4, 2025

Any question? Send us an email